問卷

TPIDB > Search Result

Search Result

篩選

List

4Cases

2022-12-07 - 2028-06-15

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2023-12-01 - 2026-11-30

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-12-01 - 2029-08-30

Phase III

Active
A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension
  • Condition/Disease

    Multiple Sclerosis (MS)

  • Test Drug

    預充填式注射劑

Participate Sites
3Sites

Recruiting3Sites

2017-09-01 - 2021-12-31

Phase III

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
  • Condition/Disease

    Genetic Disorders – Duchenne Muscular Dystrophy

  • Test Drug

    Ataluren (PTC124)

Participate Sites
2Sites

Recruiting2Sites